Biomarkers and rapid diagnostics in antibiotic stewardship

Daiana Stolz (Basel, Switzerland)

Source: International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections
Session: PG14 Antibiotic stewardship for respiratory infections
Session type: Postgraduate Course
Number: 172
Disease area: Respiratory infections

PDF journal article, handout or slidesWebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Daiana Stolz (Basel, Switzerland). Biomarkers and rapid diagnostics in antibiotic stewardship. International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Better diagnostics for targeted antibiotic therapy
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020


Antibiotic stewardship
Source: Annual Congress 2012 - Infection control of respiratory pathogens
Year: 2012


Antibiotic stewardship in the community
Source: Eur Respir Monogr 2017; 75: 111-126
Year: 2017


Rational use and stewardship of antibiotics in pediatric respiratory disease
Source: ERS Courses: Paediatric respiratory infections
Year: 2019


How to link antimicrobial and diagnostic stewardship
Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship
Year: 2019


Effective strategies for designing a stewardship program
Source: International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections
Year: 2015



Antimicrobial resistance and new therapeutic options
Source: Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era
Year: 2021


Point of care respiratory viral testing (POCT): A novel service to target appropriate antimicrobial prescription and improve antibiotic stewardship.
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018




Antibiotic stewardship in the hospital setting
Source: Eur Respir Monogr 2017; 75: 127-149
Year: 2017


Antibiotic management and resistance
Source: Eur Respir Monogr 2018; 81: 312-330
Year: 2018


Prescribing and guidelines: both must improve to combat antimicrobial resistance
Source: Eur Respir J 2012; 39: 1050
Year: 2012


Prescribing and guidelines: both must improve to combat antimicrobial resistance
Source: Eur Respir J 2011; 37: 9-11
Year: 2011


Antibiotic stewardship in respiratory infections
Source: International Congress 2016 – Respiratory infections in high-income countries: old challenges and new threats
Year: 2016


Antibiotic treatment considerations beyond guidelines
Source: International Congress 2017 – Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP)
Year: 2017


Advances in the diagnosis of mycobacteria infections and challenges of drug susceptibility testing
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019


Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008


Innovative tools for diagnosis and prevention of paediatric tuberculosis
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019